Karen Ling

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Marc Rosenbaum, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Karen Ling

Form 4 holding Director

TherapeuticsMD, Inc.

Security class
Restricted Stock Units
Shares / value
5,000
Estimated value
$18,191
Report date
29 Sep 2022
Price
$3.64
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Mallinckrodt plc

Security class
Ordinary Shares
Shares / value
0
Estimated value
Report date
14 Nov 2023
Price
$37.50
Ownership
Direct

Insider Reports Filed by Karen Ling

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .